PRECISION BIOSCIENCES INC (DTIL)

Every figure this model derived for DTIL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 37,000 PaymentsToAcquireProductiveAssets 2026-06-30
cash 87,549,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 91,549,000 AssetsCurrent 2026-06-30
current liabilities 7,140,000 LiabilitiesCurrent 2026-06-30
equity 45,293,000 StockholdersEquity 2026-06-30
interest expense 1,321,000 InterestExpenseNonoperating 2026-06-30
ocf -51,899,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 45,055,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 7,820,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up DTIL on one particular measure came for.

RatioValue
cash operating margin-60.65
current ratio12.82
current ratio reported12.82
deferred revenue growth-100.0
dilution pct86.4
fcf margin-115.27
growth cv2.12
interest cover-27.55
operating margin-80.78
owner earnings margin-132.63
revenue growth3472.96
revenue growth per share1816.83
rule of 403392.18
sbc pct revenue17.36

What to be careful about

What this model itself distrusts about DTIL's figures. Written by the derivation as it ran, not added afterwards.